论文部分内容阅读
AIM To define predictors of functional benefit of direct-acting antivirals(DAAs)in patients with chronic hepatitis C virus(HCV)infection and liver cirrhosis.METHODS We analysed a cohort of 199 patients with chronic HCV genotype 1,2,3 and 4 infection invol